Return to content in this issue


A Reply to “Efficacy and Safety of Nemolizumab for Treatment of Adult Atopic Dermatitis”

Lin L, Han Y

Department of Dermatology, the Union Hospital, Fujian Medical University, Fuzhou, People’s Republic of China

J Investig Allergol Clin Immunol 2021; Vol 31(6) : 529-530
doi: 10.18176/jiaci.0745

Key words: Nemolizumab, Atopic dermatitis